An Assessment of How Clinicians and Staff Members Use a Diabetes Artificial Intelligence Prediction Tool: Mixed Methods Study
Open accessPublished version of a preprint
Abstract
Background: Nearly one-third of patients with diabetes are poorly controlled (hemoglobin A1c≥9%). Identifying at-risk individuals and providing them with effective treatment is an important strategy for preventing poor control. Objective: This study aims to assess how clinicians and staff members would use a clinical decision support tool based on artificial intelligence (AI) and identify factors that affect adoption. Methods: This was a mixed methods study that combined semistructured interviews and surveys to assess the perceived usefulness and ease of use, intent to use, and factors affecting tool adoption. We recruited clinicians and staff members from practices that manage diabetes. During the interviews, participants reviewed a sample electronic health record alert and were informed that the tool uses AI to identify those at high risk for poor control. Participants discussed how they would use the tool, whether it would contribute to care, and the factors affecting its implementation. In a survey, participants reported their demographics; rank-ordered factors influencing the adoption of the tool; and reported their perception of the tool’s usefulness as well as their intent to use, ease of use, and organizational support for use. Qualitative data were analyzed using a thematic content analysis approach. We used descriptive statistics to report demographics and analyze the findings of the survey. Results: In total, 22 individuals participated in the study. Two-thirds (14/22, 63%) of respondents were physicians. Overall, 36% (8/22) of respondents worked in academic health centers, whereas 27% (6/22) of respondents worked in federally qualified health centers. The interviews identified several themes: this tool has the potential to be useful because it provides information that is not currently available and can make care more efficient and effective; clinicians and staff members were concerned about how the tool affects patient-oriented outcomes and clinical workflows; adoption of the tool is dependent on its validation, transparency, actionability, and design and could be increased with changes to the interface and usability; and implementation would require buy-in and need to be tailored to the demands and resources of clinics and communities. Survey findings supported these themes, as 77% (17/22) of participants somewhat, moderately, or strongly agreed that they would use the tool, whereas these figures were 82% (18/22) for usefulness, 82% (18/22) for ease of use, and 68% (15/22) for clinic support. The 2 highest ranked factors affecting adoption were whether the tool improves health and the accuracy of the tool. Conclusions: Most participants found the tool to be easy to use and useful, although they had concerns about alert fatigue, bias, and transparency. These data will be used to enhance the design of an AI tool.
AI snapshot
Written from the paper’s full text.
TL;DR
In a mixed methods study of 22 clinicians and staff, most rated a hypothetical AI diabetes risk tool as useful and easy to use and said they would use it, but adoption depended on validation, transparency, actionability, workflow fit, and concerns about alert fatigue and bias. The findings are intended to inform the design of an AI tool for poorly controlled diabetes.
Key findings
- Survey attitudes were favorable: 77% (17/22) somewhat, moderately, or strongly agreed they would use the tool; 82% (18/22) for usefulness; 82% (18/22) for ease of use; and 68% (15/22) for clinic support. Mean 1–7 ratings were 5.6 (SD 1.4) for intent to use, 5.7 (SD 1.3) for usefulness, 5.8 (SD 1.2) for ease of use, and 5.0 (SD 1.7) for clinic support.
- The highest-ranked factors affecting adoption were whether the tool improves health (mean rank 2.5, SD 1.7), accuracy (2.7, SD 1.7), and usability (3.7, SD 1.5). Asked how many of 1000 patients with diabetes the AI would need to accurately categorize, the mean was 617 (SD 264 in the text; Table 2 reports SD 273), with responses ranging from 20 to 900.
- Qualitative themes: participants saw potential value because the tool fills a gap, supports proactive and holistic care, and could improve population health; concerns included harms, overdiagnosis, punitive use, and cost (15/22, 68%), exacerbating disparities and alert fatigue (14/22, 64%), and lack of evidence for accuracy/implementation (5/22, 23%).
- Adoption was described as dependent on validation, transparency, actionability, and design; implementation would require buy-in and tailoring to local resources, with 21/22 (95%) discussing comprehensive team engagement, 20/22 (91%) wanting to share information with patients while worrying about confusion/stress, and 17/22 (77%) lacking consensus on alert timing.
Methods
- Mixed methods study combining semistructured interviews and surveys. Participants were clinicians and staff working in clinics that care for diabetes, aged ≥18 years, English speakers, recruited via the researchers’ networks; 22 individuals participated. Interviews occurred June 2021–January 2022, were web-based and audio recorded, and participants received US $50.
- The interview guide was informed by the Technology Acceptance Model. Participants reviewed a sample electronic health record alert for a clinical decision support tool using AI and EHR/neighborhood data to predict uncontrolled diabetes (HbA1c >9% over the next year), then discussed use, usefulness, concerns, and implementation factors. Qualitative data were analyzed with thematic content analysis in NVivo by 2 coders, with coding until saturation and counts of respondents per finding.
- The post-interview survey used a 7-point Likert scale for intent to use, perceived usefulness, ease of use, and organizational support; participants rank-ordered implementation factors and answered an accuracy-threshold question. Demographics were collected, and descriptive statistics were used for survey and demographic findings.
Limitations
- Stated in the paper: recruitment through the researchers’ networks meant many participants were from academic settings and FQHCs, so results may not represent primary care clinics across the United States; participants did not use a prototype, so ease-of-use and usefulness responses might have differed; and other adoption factors such as computer self-efficacy were not assessed.
- Evident from the text: the sample was small (n=22), predominantly physicians (14/22) and family medicine, and the tool was hypothetical rather than implemented, so findings reflect anticipated rather than observed use, with no patient outcomes or actual adoption behavior measured.
- Evident from the text: some reported values are inconsistent between narrative and table (e.g., accuracy SD 264 vs 273; physician percentage 63% vs 64%), which may affect precision of the reported estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
33 of 54 cited sources checked · 10 supported · 0 flagged · accuracy not yet measured
- Premisecitation
A systematic review identified only 51 studies involving AI implementation.
“A systematic review identified only 51 studies involving AI implementation [31].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] source
- Premisecitation
Of the 51 studies involving AI implementation, 6 were related to diabetes.
“Of these, 6 were related to diabetes.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] source
The Abstract Results and Results > AI Application Characteristics report 51 included AI-implementation studies and four addressing diabetic retinopathy. The References also list a study of diabetes-related complications, but the review does not give a total of six diabetes-related studies; the claimed count is not established by our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisereasoning
Primary care clinicians are particularly susceptible to burnout.
“primary care clinicians are particularly susceptible to burnout”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [29] source
The Discussion (page unavailable) says burnout is more prevalent among US physicians than among the general working population. The paper includes primary care physicians, but the passages found do not establish that primary care clinicians are particularly susceptible compared with other clinicians; its multivariate specialty table identifies emergency medicine, not primary care, as having elevated odds relative to the reference specialty. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [30] source
- Premisecitation
A 2% decrease in HbA1c (eg, from 9% to 7%) lowers the probability of microvascular complications by 50% to 76%.
“a 2% decrease in HbA1c (eg, from 9% to 7%) lowers the probability of microvascular complications by 50% to 76% [9].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [9] source
The A1C GOALS section reports that, in the DCCT trial of patients with type 1 diabetes, intensive control (mean A1C about 7%) versus standard control (about 9%) was associated with 50–76% lower rates of developing or progressing microvascular complications. The citing sentence omits that trial population and presents the result as a general effect of any 2% HbA1c decrease. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
The 2 highest ranked factors affecting adoption were whether the tool improves health and the accuracy of the tool.
“The 2 highest ranked factors affecting adoption were whether the tool improves health and the accuracy of the tool.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Findingown data
15/22 (68%) of participants somewhat, moderately, or strongly agreed that the clinic would support their use of the tool.
“68% (15/22) for clinic support”
- Also stated in: § Overview · plain
“These figures were 82% (18/22) and 68%(15/22) for ease of use and clinic support, respectively.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Also stated in: § Overview · plain
- Findingown data
18/22 (82%) of participants somewhat, moderately, or strongly agreed that the tool was useful.
“these figures were 82% (18/22) for usefulness”
- Also stated in: § Overview · plain
“whereas this figure was 18 (82%) for its usefulness.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Also stated in: § Overview · plain
- Findingown data
Clinicians and staff were concerned about how the tool affects patient-oriented outcomes and clinical workflows.
“clinicians and staff members were concerned about how the tool affects patient-oriented outcomes and clinical workflows”
- Also stated in: § Overview · plain
“Clinicians and staff were concerned about how the tool affects patient-oriented outcomes and clinic workflows”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
- Also stated in: § Overview · plain
- Findingown data
18/22 (82%) of participants somewhat, moderately, or strongly agreed that the tool was easy to use.
“82% (18/22) for ease of use”
- Also stated in: § Overview · plain
“These figures were 82% (18/22) and 68%(15/22) for ease of use and clinic support, respectively.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Also stated in: § Overview · plain
- Findingown data
11/22 (50%) participants said knowing how the tool was developed and the rationale behind why an individual is high risk allows clinicians and staff to gauge the tool's credibility.
“Knowing how the tool was developed and the rationale behind why an individual is high risk allows clinicians and staff to gauge the tool’s credibility.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
- Findingown data
17/22 (77%) of participants somewhat, moderately, or strongly agreed that they would use the tool.
“77% (17/22) of participants somewhat, moderately, or strongly agreed that they would use the tool”
- Also stated in: § Overview · plain
“Of 22 participants, 17 (77%) somewhat, moderately, or strongly agreed that they would use the tool”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Also stated in: § Overview · plain
- Findingown data
The top 3 items affecting implementation were whether the tool improved health, accuracy, and usability.
“the top 3 items were whether the tool improved health, accuracy, and usability.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Findingown data
Clinicians and staff were concerned about how the tool affects patient-oriented outcomes and clinic workflows.
“Clinicians and staff were concerned about how the tool affects patient-oriented outcomes and clinic workflows.”
Quote in the paperSubstantial claim - Findingown data
Overall, attitudes toward the tool were favorable.
“Overall, attitudes toward the tool were favorable (Table 2).”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Findingown data
Participants were concerned that the tool's accuracy and implementation would not be supported by evidence (5/22, 23%).
“Finally, participants were concerned that the tool’s accuracy and implementation would not be supported by evidence (5/22, 23%):”
Quote in the paperNot a substantial claim - Findingown data
With notable exceptions, many participants reported that their organizations lacked a systematic approach for reducing the percentage of those who are poorly controlled.
“With notable exceptions, many participants reported that their organizations lacked a systematic approach for reducing the percentage of those who are poorly controlled.”
Quote in the paperNot a substantial claim - Findingown data
There was a lack of consensus regarding when the alert should appear, with some wanting it at the point of care and others wanting to review the information outside of visits (17/22, 77%).
“There was a lack of consensus regarding when the alert should appear, with some wanting it at the point of care, whereas others wanted to review the information outside of visits (eg, periodic lists or a dashboard, 17/22, 77%):”
Quote in the paperNot a substantial claim - Premisecitation
One study examined the implementation of a tool that predicts poor glycemic control.
“One study examined the implementation of a tool that predicts poor glycemic control [32].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] source
- Interpretationown data
Our findings demonstrate that concerns about the black-box nature of AI and its role in widening disparities are not theoretical issues.
“Our findings demonstrate that these are not theoretical issues.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 60
- May combine two claims. 52
- The quote only partly states this claim. 9
Classified as probably not a substantial claim.
PremisecitationPoor control, defined as a hemoglobin A1c level >9.0%, contributes to complications, including nephropathy, retinopathy, and neuropathy.
“Poor control, defined as a hemoglobin A1c (HbA1c) level >9.0%, contributes to complications, including nephropathy [1-6], retinopathy [4,7], and neuropathy [4,8].”
Quote in the paperSubstantial claim4 of 8 sources checked- cites [1] source
The Results (p. 2) show that intensive glucose control reduced nephropathy, supporting a link between glycemic control and that complication. The paper does not define poor control as HbA1c >9.0%; it reports no significant effect on retinopathy (Results, p. 2), and its secondary-outcomes table (p. 10) does not show a reduction in neuropathy. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [2] source
- cites [3] source
The Discussion says glucose control may reduce microvascular complications, and the Microvascular Results report less worsening of albumin excretion with intensive treatment. But the paper does not define poor control as HbA1c >9.0% or establish that this threshold contributes to nephropathy, retinopathy, and neuropathy; it reports no significant treatment-group differences in those three outcomes. Page numbers were not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [4] source
The Discussion’s summary of main results reports that intensive glucose control reduces the risk of developing retinopathy, nephropathy, and neuropathy compared with conventional treatment. But the review does not define poor control as HbA1c >9.0% or establish that threshold for these complications; its Figure 4 uses 9.0% to stratify risk of severe hypoglycaemia. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [5] source
- cites [6] source
The Introduction reports an association between poor glycemic control and microvascular complications in type 2 diabetes, and the Results > Outcomes section finds that intensive control reduced albuminuria. The paper does not define poor control as HbA1c >9.0% or establish that poor control causes nephropathy; it also finds no demonstrated reduction in clinical renal endpoints. This citation is attached to nephropathy, not to the sentence’s separate retinopathy and neuropathy claims. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [7] source
- cites [8] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn federally qualified health centers, the percentage with poor control was 32% in 2016, up from 29% in 2009.
“In federally qualified health centers (FQHCs), the percentage with poor control was 32% in 2016 (up from 29% in 2009)”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [13] source
The Abstract identifies 2009 data, and the Results report that 71.0% of diabetic patients had controlled HbA1c levels—implying 29.0% did not meet that control measure. The paper provides no 2016 figure, so it does not support the claimed increase to 32%. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [14] National Health Center Program Uniform Data System (UDS) Awardee DataHealth Resources & Services Administration2018-02-22https://bphc.hrsa.gov/uds/datacenter.aspx#fn8
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationMost of these studies used quantitative methods and examined tools that have already been developed.
“Most of these studies used quantitative methods and examined tools that have already been developed [35-37].”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [35] source
The Results, Summary of Included Studies (page unavailable), says that most of the 48 studies evaluated AI from the user perspective, which supports the claim that they examined tools. It does not establish that most used quantitative methods or that the tools had already been developed; it also describes studies focused on algorithm development. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [36] source
The Results (Study Characteristics) report that 7 of 31 studies used qualitative methods, supporting the claim that most used other, largely quantitative designs. The Results (Risk-of-Bias and Quality Assessments) also describe some studies developing and initially evaluating agents; the review does not establish that most examined tools developed before the studies began. Page numbers are unavailable in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [37] source
The Methods (Data Analysis; page unavailable) report quantitative usability statistics for an app that participants used, supporting the claim that this study examined a functioning tool. But the same section reports qualitative interview analysis, and Methods (Development of GUI; page unavailable) describes developing and iteratively refining the app. This paper therefore does not support characterizing its approach as solely quantitative or its tool as already developed independently of the study. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationResearchers and clinicians are using artificial intelligence to integrate electronic health records and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control.
“researchers and clinicians are using artificial intelligence (AI) to integrate electronic health records (EHRs) and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control [17-22].”
Quote in the paperSubstantial claim3 of 6 sources checked- cites [17] source
- cites [18] source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [19] source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [20] DevireddyLDunnDShermanMA feature-selection based approach for the detection of diabetes in electronic health record dataMichael W Sherman2014572023-05-17http://www.michaelwsherman.com/projects/diabetes/report.pdf
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [21] Berkman, LF, 2014, Social Epidemiology (2 edition)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [22] source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationSociotechnical theory posits that the implementation of technology depends on values, mindsets, and communication and is an evolutionary process best achieved by early and active engagement with frontline workers.
“The sociotechnical theory posits that the implementation of technology depends on values, mindsets, and communication and is an evolutionary process best achieved by early and active engagement with frontline workers [33,34].”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe implementation of AI tools for diabetes has lagged, and few tools are used in practice, limiting their impact.
“Unfortunately, the implementation of AI tools for diabetes has lagged, and few tools are used in practice, limiting their impact.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [31] source
The Introduction (Background; page not provided) says health care AI implementation is not widespread and that its potential depends on integration into routine workflows. The Results (AI Application Characteristics; page not provided) identify four studies of diabetic-retinopathy applications, but the review does not establish that few diabetes tools are used in practice or measure whether limited use has reduced their impact. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThese applications used computer vision to diagnose diabetic retinopathy from retinal images and electronic health record data to predict those at risk for hyperglycemia.
“These applications used computer vision to diagnose diabetic retinopathy from retinal images and EHR data to predict those at risk for hyperglycemia.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] source
The Results > Evaluation Outcomes section (page unavailable) reports an AI diagnostic system for diabetic retinopathy and gives its imageability rate, supporting the retinopathy-detection part of the claim. It does not specify computer vision or retinal images in that passage. Searches for hyperglycemia and EHR-based risk prediction found no passage supporting the second part. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Technology Acceptance Model explains approximately 40% of the variance in individuals' intention to use a new technology and actual use.
“The model explains approximately 40% of the variance in individuals’ intention to use a new technology and actual use [39].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [39] source
Classified as probably not a substantial claim.
PremisecitationThe Technology Acceptance Model theorizes that individuals' intention to use new technology is determined by perceived usefulness and perceived ease of use.
“It theorizes that individuals’ intention to use new technology is determined by perceived usefulness, defined as “the extent to which a person believes that using [a new technology] will enhance his or her job performance,” and perceived ease of use, defined as “the degree to which a person believes that using [a new technology] will be free of effort” [39].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationUsability of and satisfaction with AI tools are generally high.
“researchers are starting to pay attention to end users [35] and are finding that usability of and satisfaction with AI tools are generally high [35-37].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [35] source
The Results’ Summary of Included Studies reports that most patients found one AI symptom checker easy to use and that 19 of 20 children found a chatbot easy to use. These examples support positive usability findings, but the review does not establish that usability and satisfaction with AI tools are generally high across the studies it covers; its Perception, Usability, Workload, and Trust section also describes usability barriers. No page numbers were provided in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [36] source
The Results (Overall Evaluation of Conversational Agents) report positive or mixed evidence for perceived ease of use or usefulness in 27/30 studies and satisfaction in 26/31. This supports a generally favorable assessment, but the review covers health care conversational agents—not AI tools broadly—and combines positive with mixed results rather than establishing that ratings were generally high. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [37] source
The Results (Satisfaction) report a mean usability score of 91.94, rated “excellent,” and the Discussion (Principal Findings) says clinicians found the app intuitive and easy to use. The study assessed one COVID-19 prediction app at a single hospital, so it does not establish that usability and satisfaction are generally high across AI tools. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe number of Americans with poorly controlled diabetes has been increasing, contributing to preventable morbidity and mortality.
“The number of Americans with poorly controlled diabetes has been increasing, contributing to preventable morbidity and mortality [10-12].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [10] Comprehensive Diabetes Care (CDC)NCQA2017-11-29http://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality/2016-table-of-contents/diabetes-care
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11] Quality: Traditional MIPS RequirementsQuality Payment Program2017-11-29https://qpp.cms.gov/mips/quality-measures
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [12] source
The Introduction (page not available in our copy) says that type 2 diabetes prevalence is growing and that poor glycemic control increases the risk of complications, which supports the morbidity concern. It does not establish that the number of Americans with poorly controlled diabetes is increasing or specifically link poor control to mortality. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCommunities with poor housing, transportation, poverty, and education have higher rates of diabetes.
“communities with poor housing, transportation, poverty, and education have higher rates of diabetes [23-25].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [23] source
- cites [24] source
- cites [25] source
The Introduction and Discussion (pages unavailable) report an association between neighborhood deprivation and type 2 diabetes. The Methods define deprivation using low income and low education, among other indicators, but do not include poor housing or transportation. The source therefore supports the poverty and education aspects, not the full list of community conditions. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataOur respondents asked for steps that could be taken in response to predictions and wanted to know that those actions would lead to better health, echoing the sentiment found in other studies.
“Although usability and accuracy were deemed important, our respondents asked for steps that could be taken in response to predictions and wanted to know that those actions would lead to better health, echoing the sentiment found in other studies [35].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [35] source
In Results > Summary of Included Studies (page unavailable), the review reports that tailored recommendations were important to stakeholders designing a risk-prediction tool and that some patients lacked information about self-management. This supports the desire for steps to take, but our copy does not report that users wanted assurance those steps would lead to better health. (LLM, conf=0.79)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFor many years, researchers and policy makers have issued warnings regarding the black-box nature of AI and its role in widening disparities.
“For many years, researchers and policy makers have issued warnings regarding the black-box nature of AI and its role in widening disparities [43,44].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [43] source
The introduction (p. 2) describes growing concern that algorithms may reproduce disparities and says proprietary algorithms are difficult for independent researchers to examine. It does not establish that both researchers and policymakers have issued warnings for many years. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [44] FjeldJAchtenNHilligossHNagyASrikumarMPrincipled artificial intelligence: mapping consensus in ethical and rights-based approaches to principles for AIBerkman Klein Center for Internet & Society20202023-05-17https://dash.harvard.edu/handle/1/42160420
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther clinicians have responded favorably to the usability of tools that use AI.
“For example, similar to our results, other clinicians have responded favorably to the usability of tools that use AI [36,37].”
Quote in the paperNot a substantial claim2 of 2 sources checkedMay combine two claims.
Findingown data21/22 (95%) participants said responding to the tool in a comprehensive manner requires the engagement of a comprehensive team; there was strong consensus regarding the role of clinicians and nurses, but ambivalence regarding administrators and patients.
“Responding to the tool in a comprehensive manner requires the engagement of a comprehensive team. Although there was strong consensus regarding the role of clinicians and nurses, participants expressed ambivalence regarding administrators and patients.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
The quote only partly states this claim.
Findingown data5/22 (23%) participants were concerned that the tool's accuracy and implementation were not supported by evidence.
“Participants were concerned that the tool’s accuracy and implementation were not supported by evidence.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 22 participants, 14 (63%) were physicians.
“Two-thirds (14/22, 63%) of respondents were physicians.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data2/22 (9%) participants said the ability to customize the tool is important because implementation could differ across practices and clinicians.
“The ability to customize the tool is important because implementation could differ across practices and clinicians.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown data8/22 (36%) participants said successful implementation would require trialability, training, interoperability, and buy-in.
“Successful implementation would require trialability, training, interoperability, and buy-in.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
Findingown dataOther participants argued that the tool would facilitate the delivery of proactive care, building on the core function of primary care.
“Other participants argued that the tool would facilitate the delivery of proactive care, building on the core function of primary care”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
Findingown dataImplementation would require buy-in and need to be tailored to the demands and resources of clinics and communities.
“implementation would require buy-in and need to be tailored to the demands and resources of clinics and communities”
- Also stated in: § Overview · hedged
“Implementation would require buy-in and need to be tailored to the demands and resources of clinics and communities”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
- Also stated in: § Overview · hedged
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn total, 22 individuals participated in the study.
“In total, 22 individuals participated in the study.”
- Also stated in: § Overview · plain
“In total, 22 individuals participated in this study.”
Quote in the paperNot a substantial claim- Also stated in: § Overview · plain
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown data19/22 (86%) participants recommended integrating functionality and relevant information from within the EHR.
“Participants recommended integrating functionality and relevant information from within the EHRa.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims.
Findingown data20/22 (91%) participants wanted to share this information with patients to empower them and support transparency but were also concerned that the information would cause confusion and stress.
“Participants wanted to share this information with patients to empower them and support transparency but were also concerned that the information would cause confusion and stress.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims.
Findingown dataAdoption of the tool is dependent on its validation, transparency, actionability, and design and could be increased with changes to the interface and usability.
“adoption of the tool is dependent on its validation, transparency, actionability, and design and could be increased with changes to the interface and usability”
- Also stated in: § Overview · hedged
“Adoption of the tool is dependent on its validation, transparency, actionability, and design and could be increased with changes to the interface and usability”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
- Also stated in: § Overview · hedged
Classified as probably not a substantial claim. May combine two claims. The quote only partly states this claim.
Findingown data6/22 (27%) participants said to act on the information, clinicians and staff need to understand which risk factors are modifiable and which actions will have the greatest impact on lowering risk.
“To act on the information, clinicians and staff need to understand which risk factors are modifiable and which actions will have the greatest impact on lowering risk.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data7/22 (32%) participants noted that such a tool does not exist and that it would fill a gap.
“several participants (7/22, 32%) noted that such a tool does not exist and that it would fill a gap”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown data22/22 (100%) participants recommended other events that could be predicted, including cardiovascular disease, uncontrolled hypertension, worsening depression, care gaps, and missed appointments.
“Participants recommended other events that could be predicted, including cardiovascular disease, uncontrolled hypertension, worsening depression, care gaps (eg, preventive services), and missed appointments.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims.
Findingown data17/22 (77%) participants lacked consensus regarding when the alert should appear, with some wanting it at the point of care and others wanting to review the information outside of visits.
“There was a lack of consensus regarding when the alert should appear, with some wanting it at the point of care, whereas others wanted to review the information outside of visits (eg, periodic lists or a dashboard).”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims.
Findingown data12/22 (55%) participants said the local context affects what can be done in response to the information provided by the tool, and participants will become frustrated if the tool recommends an option that is not available.
“The local context affects what can be done in response to the information provided by the tool. Conversely, participants will become frustrated if the tool recommends an option that is not available.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Findingown data8/22 (36%) participants thought the utility is limited for clinicians who know their patients well or have access to existing programs, and some would rather focus on people who are already uncontrolled.
“The utility is limited for those clinicians who know their patients well or have access to existing programs, and some would rather focus on people who are already uncontrolled.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims.
Findingown dataThe mean number of people (out of 1000) whose prognosis the tool would need to accurately predict for participants to consider using it was 617 (SD 264), with responses ranging from 20 to 900.
“the mean number of people whose prognosis the tool would need to accurately predict was 617 (SD 264), although the responses ranged from 20 to 900.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data4/22 (18%) participants said the tool needs to be validated against patient-oriented outcomes so that clinics can quantify the potential return on their investment.
“The tool needs to be validated against patient-oriented outcomes so that clinics can quantify the potential return on their investment.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
May combine two claims. The quote only partly states this claim.
Findingown data15/22 (68%) participants were concerned the tool would lead to harms, contribute to overdiagnosis, be used punitively, and make care more expensive.
“Participants were concerned the tool would lead to harms, contribute to overdiagnosis, be used punitively, and make care more expensive.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Classified as probably not a substantial claim. May combine two claims.
Findingown dataThe tool has the potential to be useful because it provides information that is not currently available and can make care more efficient and effective.
“this tool has the potential to be useful because it provides information that is not currently available and can make care more efficient and effective”
- Also stated in: § Theme 1 · plain
“The tool has the potential to be useful because it provides information that is not currently available and can make care more efficient and effective.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
- Also stated in: § Theme 1 · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 22 participants, 6 (27%) worked in federally qualified health centers.
“whereas 27% (6/22) of respondents worked in federally qualified health centers.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown data14/22 (64%) participants were concerned that the tool would exacerbate existing problems, such as health disparities and alert fatigue.
“Participants were concerned that the tool would exacerbate existing problems, such as health disparities and alert fatigue.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown data13/22 (59%) participants said using user-centered design principles has the potential to minimize the tool's impact on workflows and maximize readability.
“Using user-centered design principles has the potential to minimize the tool’s impact on workflows and maximize readability.”
Quote in the paperNot a substantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 22 participants, 8 (36%) worked in academic health centers.
“Overall, 36% (8/22) of respondents worked in academic health centers”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants believed that perceived usability and readability would be key drivers of adoption (13/22, 59%).
“Participants believed that perceived usability and readability would be key drivers of adoption (13/22, 59%):”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParticipants wanted to understand which risk factors are modifiable and which actions will have the greatest impact on lowering risk, in addition to knowing why someone is at high risk (6/22, 27%).
“Knowing why someone is at high risk is necessary but insufficient. Participants also wanted to understand which risk factors are modifiable and which actions will have the greatest impact on lowering risk (6/22, 27%):”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataClinicians who know their patients well or have access to existing programs thought the tool's utility was limited, and some would rather focus on people who are already uncontrolled (8/22, 36%).
“In particular, those clinicians who know their patients well or have access to existing programs thought the utility was limited, and some would rather focus on people who are already uncontrolled (8/22, 36%):”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataClinicians and staff believed that using the tool would increase their focus on diabetes by scheduling more frequent visits, interacting with patients between visits, managing diabetes even when acute issues emerge, and providing targeted education (20/22, 91%).
“As a result of using the tool, clinicians and staff thought they would increase their focus on diabetes by scheduling more frequent visits, interacting with patients in between visits, managing diabetes even when acute issues emerge, and providing targeted education (20/22, 91%):”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataParticipants were ambivalent about the tool's impact on susceptible populations: some thought these patients needed attention most, while others thought making a positive impact would be difficult (7/22, 32%).
“Participants were ambivalent about the tool’s impact on susceptible populations. Some participants thought that these were the patients who needed attention the most, whereas others thought that making a positive impact would be difficult (7/22, 32%):”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe sample was predominantly women, Hispanic, and physicians.
“They were predominantly women, Hispanic, and physicians (Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParticipants expected a degree of transparency and wanted to know how the tool was developed and the rationale behind the high risk of an individual, which allows them to gauge the tool's credibility (11/22, 50%).
“The participants expected a degree of transparency and wanted to know how the tool was developed and the rationale behind the high risk of an individual. This information allows them to gauge the tool’s credibility (11/22, 50%):”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
Findingown dataParticipants believed the tool needs to be validated against patient-oriented outcomes so that clinics can quantify the potential return on investment (4/22, 18%).
“The tool needs to be validated against patient-oriented outcomes so that clinics can quantify the potential return on investment (4/22, 18%):”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants believed that by integrating information about mental health and social risk factors, the tool would facilitate individualized, holistic care (11/22, 50%).
“By integrating information about mental health and social risk factors, our participants (11/22, 50%) believed that the tool would facilitate individualized, holistic care:”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe sample included a nurse practitioner, physician assistant, behavioral therapist, and social worker.
“The sample also included a nurse practitioner, physician assistant, behavioral therapist, and social worker.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOthers believed the tool could be used to improve elements of population health, such as improving the quality of care delivered and allocating resources to high-need patients (10/22, 45%).
“Others believed that the tool could be used to improve elements of population health, such as improving the quality of care delivered and allocating resources to high-need patients (10/22, 45%):”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParticipants were concerned that the tool would lead to harms, contribute to overdiagnosis, be used punitively, and make care more expensive (15/22, 68%).
“Participants had myriad concerns about the tool. First, they were concerned that the tool would lead to harms, contribute to overdiagnosis, be used punitively, and make care more expensive (15/22, 68%):”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants were concerned that the tool would exacerbate existing issues such as health disparities and alert fatigue.
“They were also concerned that the tool would exacerbate existing issues such as health disparities and alert fatigue:”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingown dataRespondents wanted to be able to tailor the tool to their local environment, noting that the suggestions offered and the recipients of the information needed to be customized to the resources, needs, and workflows of their unique clinics.
“Finally, they wanted to be able to tailor the tool to their local environment, noting that the suggestions offered and the recipients of the information needed to be customized to the resources, needs, and workflows of their unique clinics.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataSuccessful implementation would require trialability, training, interoperability, and buy-in (8/22, 36%).
“Successful implementation would require trialability, training, interoperability, and buy-in (8/22, 36%):”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataParticipants thought the model could be applied to other conditions and recommended the tool be used to predict important events in primary care, including cardiovascular disease, uncontrolled hypertension, worsening depression, care gaps, and missed appointments (22/22, 100%).
“Participants thought that this model could be applied to other conditions and recommended that the tool be used to predict important events in primary care, including cardiovascular disease, uncontrolled hypertension, worsening depression, care gaps (eg, preventive services), and missed appointments (22/22, 100%):”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataParticipants believed that the tool could improve population health and contribute to individualized care.
“They also believed that the tool could improve population health and contribute to individualized care.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataParticipants wanted to share information with patients to empower them and support transparency but were concerned that the information would cause confusion and stress (20/22, 91%).
“Participants wanted to share this information with patients to empower them and support transparency but were also concerned that the information would cause confusion and stress (20/22, 91%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThey are concerned about how AI can perpetuate the racial biases embedded within data sets and about their role in supporting biased systems.
“They are concerned about how AI can perpetuate the racial biases embedded within data sets and about their role in supporting biased systems.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDuring the interviews, participants noted that the tool is not available now and would generally change their behavior.
“During the interviews, they noted that the tool is not available now and would generally change their behavior.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataOthers were concerned that AI would perpetuate biases and that alert fatigue would contribute to burnout.
“Others were concerned that AI would perpetuate biases and that alert fatigue would contribute to burnout.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants believed the ability to customize the tool is important because implementation could differ across practices and clinicians (2/22, 9%).
“The ability to customize the tool is important because implementation could differ across practices and clinicians (2/22, 9%):”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants recommended integrating functionality and relevant information within the EHR (19/22, 86%).
“Participants recommended integrating functionality and relevant information within the EHR (19/22, 86%).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingown dataTo gauge the tool's credibility, participants wanted to know why the patients were at high risk and what they could do to reduce that risk.
“To gauge the tool’s credibility, they wanted to know why the patients were at high risk and what they could do to reduce that risk.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataParticipants were concerned about alert fatigue, bias, and transparency.
“Conversely, participants were concerned about alert fatigue, bias, and transparency.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe tool was not uniformly accepted; several respondents indicated that it did not provide useful information for patients well known to the practice and for practices already offering comprehensive services.
“Despite these benefits, the tool was not uniformly accepted, with several respondents indicating that it did not provide useful information for those patients who are well known to the practice and for those practices already offering comprehensive services.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataParticipants thought that information without context could be harmful and that they would need scripts to explain the results in a patient-centric manner.
“They thought that the information without context could be harmful and that they would need scripts to explain the results in a patient-centric manner:”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFrom the surveys, respondents found the tool to be useful and easy to use and, if available, would use it.
“From the surveys, respondents found the tool to be useful and easy to use and, if available, would use it.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenMost participants found the tool to be easy to use and useful.
“Most participants found the tool to be easy to use and useful.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingreasoningAll members of the primary care team have potential roles to play, including front desk personnel, pharmacists, and social workers, and the recipients of the information may be practice dependent.
“All members of the primary care team have potential roles to play, including front desk personnel, pharmacists, and social workers. As roles differ for each practice, the recipients of the information may be practice dependent:”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe local context affects what can be performed in response to the information provided by the tool, and participants will become frustrated if the tool recommends an option that is not available (12/22, 55%).
“The local context affects what can be performed in response to the information provided by the tool. Conversely, participants will become frustrated if the tool recommends an option that is not available (12/22, 55%):”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTo enhance adoption, respondents wanted to know why the patients were at risk and what could be done to reduce that risk.
“To enhance adoption, respondents wanted to know why the patients were at risk and what could be done to reduce that risk.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe clinicians and staff members in our study called for greater explainability, wanted these issues explicitly acknowledged and addressed, and cautioned that these tools will continue to languish on shelves in the absence of satisfactory solutions.
“The clinicians and staff members in our study called for greater explainability (ie, justifications for the tool’s output), wanted these issues explicitly acknowledged and addressed, and cautioned that these tools will continue to languish on shelves in the absence of satisfactory solutions [44].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] FjeldJAchtenNHilligossHNagyASrikumarMPrincipled artificial intelligence: mapping consensus in ethical and rights-based approaches to principles for AIBerkman Klein Center for Internet & Society20202023-05-17https://dash.harvard.edu/handle/1/42160420
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataResponding to the tool in a comprehensive manner requires the engagement of a comprehensive team; there was strong consensus regarding the role of clinicians and nurses, but ambivalence regarding administrators and patients (21/22, 95%).
“Responding to the tool in a comprehensive manner requires the engagement of a comprehensive team. Although there was strong consensus regarding the role of clinicians and nurses, participants expressed ambivalence regarding administrators and patients (21/22, 95%).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMost participants found the tool to be easy to use and useful, although they had concerns about alert fatigue, bias, and transparency.
“Most participants found the tool to be easy to use and useful, although they had concerns about alert fatigue, bias, and transparency.”
Quote in the paperSubstantial claim- Rests on an assumption: The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
- Rests on an assumption: Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe protocol was approved by the Institutional Review Board of the University of Houston (STUDY00002980).
“The protocol was approved by the Institutional Review Board of the University of Houston (STUDY00002980).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe coders independently applied codes in a second reading and met to reconcile coding discrepancies and modify the codebook.
“Using the updated codebook, the coders independently applied codes to the interviews in a second reading and met to reconcile coding discrepancies and modify the codebook (version 2).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn that study, only 14% (4/28) of users indicated that they would recommend the tool to others, and many users reported that the interventions were inappropriate or not useful.
“only 14% (4/28) of users indicated that they would recommend the tool to others, and many users reported that the interventions were inappropriate or not useful [32].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] source
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningTaken together, these studies indicate that a greater focus on AI implementation and end-user engagement during development are needed to tailor tools to clinical resources and workflows.
“Taken together, these studies indicate that a greater focus on AI implementation and end-user engagement during development are needed to tailor tools to clinical resources and workflows.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDigitization risks overwhelming clinicians.
“Although this digitization offers tremendous opportunities for prediction, it also risks overwhelming clinicians [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Medscape lifestyle report 2016: bias and burnoutMedscape2021-03-22https://www.medscape.com/slideshow/lifestyle-2016-overview-6007335
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe national target for poor control in Healthy People 2030 is 11.6%.
“the metric has been included in Healthy People 2030, which sets the national target at 11.6%”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15] Reduce the proportion of adults with diabetes who have an A1c value above 9 percentOffice of Disease Prevention and Health Promotion2022-09-06https://tinyurl.com/dkx26uwx
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [16] Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)Centers for Medicare & Medicaid Services2021-08-13https://qpp.cms.gov/docs/ecqm-specs/2017/EC_CMS122v5_NQF0059_Diab_HbA1c_Ctrl/CMS122v5.html
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
Interpretationown dataAdoption of the tool is dependent on its validation, transparency, actionability, and design, and could be increased by changing the interface and usability.
“Adoption of the tool is dependent on its validation, transparency, actionability, and design and could be increased by changing the interface and usability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe amount of data available to clinicians has increased exponentially with the growth of electronic health records, remote patient monitoring, and geo-tracking.
“With the growth of EHRs, remote patient monitoring, and geo-tracking, the amount of data available to clinicians has increased exponentially [26].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] CulbertsonNThe skyrocketing volume of healthcare data makes privacy imperativeForbes2021862022-08-29https://www.forbes.com/sites/forbestechcouncil/2021/08/06/the-skyrocketing-volume-of-healthcare-data-makes-privacy-imperative/
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe transcripts were coded by 2 individuals using thematic content analysis in NVivo.
“The transcripts were coded by 2 individuals using thematic content analysis in NVivo (QSR International).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataCoding stopped once study objectives were saturated, indicating that no new information was identified.
“Coding stopped once study objectives were saturated, indicating that no new information was identified.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenWe did not ask participants to use a prototype of the tool when responding to the questions; if they had, their responses regarding ease of use and usefulness may have been different.
“Second, we did not ask the participants to use a prototype of the tool when responding to the questions. If they had, their responses to the questions regarding ease of use and usefulness may have been different.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWe did not assess other factors that influence adoption, such as computer self-efficacy.
“Finally, we did not assess other factors that influence adoption, such as computer self-efficacy, that we did not assess.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationcitationOur findings align with, and build on, the work of others.
“Our findings align with, and build on, the work of others.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningTaken together, these findings highlight the importance of the tool's actionability, explainability, and harm minimization for its implementation and provide a blueprint for researchers interested in developing AI tools for primary care settings.
“Taken together, these findings highlight the importance of the tool’s actionability, explainability, and harm minimization (resulting from bias and workflow disruptions) for its implementation and provide a blueprint for researchers interested in developing AI tools for primary care settings.”
Quote in the paperNot a substantial claim- Rests on an assumption: End-user input before a prototype is created is important for adoption of an AI tool.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningBecause participants were recruited from our networks, many were from academic settings and FQHCs; results may differ if the sample were more representative of primary care clinics across the United States.
“First, because we recruited participants from our networks, many of them were from academic settings and FQHCs. Our results may differ if we had a sample that is more representative of primary care clinics across the United States.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The sample electronic health record alert and description of the AI tool were realistic enough that participants’ responses reflect how they would use an actual tool.
“During the interview, participants were asked to review a sample EHR alert and were informed that their clinic is considering the implementation of a clinical decision support tool that uses AI.”
“The alert indicates that the fictional patient is at high risk for having an HbA1c level of >9% over the next year.”
The paper relies on this without support.
Participants’ responses about a hypothetical tool that has yet to be created can identify factors that affect adoption of the eventual tool.
“This study is novel because it qualitatively assesses the use of a poorly controlled diabetes risk tool that has yet to be created”
“During the interview, participants were asked to review a sample EHR alert and were informed that their clinic is considering the implementation of a clinical decision support tool that uses AI.”
The paper relies on this without support.
End-user input before a prototype is created is important for adoption of an AI tool.
“However, we contend that incorporating input from end users before a prototype is created is important for adoption.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Standard deviation for the required prediction accuracy differs
MinorThe Results text reports an SD of 264 for the mean of 617, but Table 2 reports an SD of 273 for the same measure.
“the mean number of people whose prognosis the tool would need to accurately predict was 617 (SD 264), although the responses ranged from 20 to 900.”
“617 (273); 20-900”
Poor control is defined using two different HbA1c thresholds
MinorThe abstract includes patients whose HbA1c is exactly 9%, whereas the Introduction's definition excludes them.
“Nearly one-third of patients with diabetes are poorly controlled (hemoglobin A1c≥9%).”
“Poor control, defined as a hemoglobin A1c (HbA1c) level >9.0%,”
Cites
Technology Acceptance Model 3 and a Research Agenda on Interventions
Venkatesh, V., & Bala, H. (2008) · Decision Sciences · doi:10.1111/j.1540-5915.2008.00192.x · Cited by 8,159 · cited 2× · see citing works
“…is determined by perceived usefulness, defined as “the extent to which a person believes that using [a new technology] will enhance his or her job performance,” and perceived ease of use, defined as “the degree to which a person believes that using [a new technology] will be free of effort” [39].”
BackgroundEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1× · see citing works
“Poor control, defined as a hemoglobin A 1c (HbA 1c ) level >9.0%, contributes to complications, including nephropathy [1-6], retinopathy [4,7], and neuropathy [4,8].”
BackgroundInfluentialDissecting racial bias in an algorithm used to manage the health of populations
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019) · Science · doi:10.1126/science.aax2342 · Cited by 7,137 · cited 1× · see citing works
“For many years, researchers and policy makers have issued warnings regarding the black-box nature of AI and its role in widening disparities [43,44].”
BackgroundGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1× · see citing works
“0%, contributes to complications, including nephropathy [1-6], retinopathy [4,7], and neuropathy [4,8].”
BackgroundGreenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., A'Court, C., Hinder, S., Fahy, N., Procter, R., & Shaw, S. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.8775 · Cited by 2,887 · cited 1× · see citing works
“The sociotechnical theory posits that the implementation of technology depends on values, mindsets, and communication and is an evolutionary process best achieved by early and active engagement with frontline workers [33,34].”
BackgroundShanafelt, T. D., Hasan, O., Dyrbye, L. N., Sinsky, C., Satele, D., Sloan, J., & West, C. P. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.08.023 · Cited by 2,885 · see citing works
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301 · see citing works
Moltu, C., Stefansen, J., Svisdahl, M., & Veseth, M. (2012) · Disability and Rehabilitation · doi:10.3109/09638288.2012.656792 · Cited by 1,247 · see citing works
Fjeld, J., Achten, N., Hilligoss, H., Nagy, A., & Srikumar, M. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3518482 · Cited by 998 · cited 2× · see citing works
“For many years, researchers and policy makers have issued warnings regarding the black-box nature of AI and its role in widening disparities [43,44].”
BackgroundShanafelt, T. D., West, C. P., Sinsky, C., Trockel, M., Tutty, M., Satele, D. V., Carlasare, L. E., & Dyrbye, L. N. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.023 · Cited by 914 · cited 1× · see citing works
“As a result of these functions, primary care clinicians are particularly susceptible to burnout, and it remains to be seen whether AI can help [29,30].”
Background6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2020</i>
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744 · cited 1× · see citing works
“%) lowers the probability of microvascular complications by 50% to 76% [9].”
BackgroundKrieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H., & Subramanian, S. V. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.10.1655 · Cited by 711 · cited 1× · see citing works
“To meet these goals, researchers and clinicians are using artificial intelligence (AI) to integrate electronic health records (EHRs) and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control [17-22].”
BackgroundThe Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694 · cited 1× · see citing works
“5 (23) Participants were concerned that the tool’s accuracy and implementation were not supported by evidence.”
BackgroundButler, D. C., Petterson, S., Phillips, R. L., & Bazemore, A. W. (2013) · Health Services Research · doi:10.1111/j.1475-6773.2012.01449.x · Cited by 689 · cited 1× · see citing works
“For instance, communities with poor housing, transportation, poverty, and education have higher rates of diabetes [23-25].”
BackgroundMuehlematter, U. J., Daniore, P., & Vokinger, K. N. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30292-2 · Cited by 665 · cited 1× · see citing works
“As a result of these functions, primary care clinicians are particularly susceptible to burnout, and it remains to be seen whether AI can help [29,30].”
BackgroundThe Effectiveness of Artificial Intelligence Conversational Agents in Health Care: Systematic Review
Milne-Ives, M., de Cock, C., Lim, E., Shehadeh, M. H., de Pennington, N., Mole, G., Normando, E., & Meinert, E. (2020) · Journal of Medical Internet Research · doi:10.2196/20346 · Cited by 626 · cited 1× · see citing works
“For example, similar to our results, other clinicians have responded favorably to the usability of tools that use AI [36,37].”
ResultThe Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602 · cited 1× · see citing works
“Poor control, defined as a hemoglobin A 1c (HbA 1c ) level >9.0%, contributes to complications, including nephropathy [1-6], retinopathy [4,7], and neuropathy [4,8].”
BackgroundInfluentialPrinciples of Sociotechnical Design Revisted
Cherns, A. (1987) · Human Relations · doi:10.1177/001872678704000303 · Cited by 545 · cited 1× · see citing works
“The sociotechnical theory posits that the implementation of technology depends on values, mindsets, and communication and is an evolutionary process best achieved by early and active engagement with frontline workers [33,34].”
BackgroundRole of Artificial Intelligence Applications in Real-Life Clinical Practice: Systematic Review
Yin, J., Ngiam, K. Y., & Teo, H. H. (2021) · Journal of Medical Internet Research · doi:10.2196/25759 · Cited by 419 · cited 1× · see citing works
“A systematic review identified only 51 studies involving AI implementation [31].”
BackgroundStrohm, L., Hehakaya, C., Ranschaert, E. R., Boon, W. P. C., & Moors, E. H. M. (2020) · European Radiology · doi:10.1007/s00330-020-06946-y · Cited by 329 · cited 1× · see citing works
“Similar to others, they also regarded the technology with skepticism [35,41,42].”
ResultPrimary Care: A Critical Review Of The Evidence On Quality And Costs Of Health Care
Friedberg, M. W., Hussey, P. S., & Schneider, E. C. (2010) · Health Affairs · doi:10.1377/hlthaff.2010.0025 · Cited by 309 · cited 1× · see citing works
“This is true for primary care, which influences downstream spending and is responsible for whole person care that spans organs and diseases and serves as a point of integration with public health and behavioral health [28].”
BackgroundIntensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299 · cited 1× · see citing works
“Poor control, defined as a hemoglobin A 1c (HbA 1c ) level >9.0%, contributes to complications, including nephropathy [1-6], retinopathy [4,7], and neuropathy [4,8].”
BackgroundInfluentialBasu, S., Sussman, J. B., Berkowitz, S. A., Hayward, R. A., & Yudkin, J. S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30221-8 · Cited by 206 · cited 1× · see citing works
“To meet these goals, researchers and clinicians are using artificial intelligence (AI) to integrate electronic health records (EHRs) and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control [17-22].”
BackgroundExploring stakeholder attitudes towards AI in clinical practice
Scott, I. A., Carter, S. M., & Coiera, E. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2021-100450 · Cited by 193 · cited 1× · see citing works
“Similar to others, they also regarded the technology with skepticism [35,41,42].”
ResultRomero-Brufau, S., Wyatt, K. D., Boyum, P., Mickelson, M., Moore, M., & Cognetta-Rieke, C. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.104072 · Cited by 143 · cited 2× · see citing works
“One study examined the implementation of a tool that predicts poor glycemic control [32].”
BackgroundResearch Trends in Artificial Intelligence Applications in Human Factors Health Care: Mapping Review
Asan, O., & Choudhury, A. (2021) · JMIR Human Factors · doi:10.2196/28236 · Cited by 114 · cited 4× · see citing works
“As the absence of engagement has the potential to reduce trust and increase errors, researchers are starting to pay attention to end users [35] and are finding that usability of and satisfaction with AI tools are generally high [35-37].”
BackgroundResultInfluentialUse of a Checklist and Clinical Decision Support Tool Reduces Laboratory Use and Improves Cost
Algaze, C. A., Wood, M., Pageler, N. M., Sharek, P. J., Longhurst, C., & Shin, A. Y. (2015) · PEDIATRICS · doi:10.1542/peds.2014-3019 · Cited by 109 · see citing works
Locality deprivation and Type 2 diabetes incidence: A local test of relative inequalities
Cox, M., Boyle, P. J., Davey, P. G., Feng, Z., & Morris, A. D. (2007) · Social Science & Medicine · doi:10.1016/j.socscimed.2007.05.043 · Cited by 106 · cited 1× · see citing works
“For instance, communities with poor housing, transportation, poverty, and education have higher rates of diabetes [23-25].”
BackgroundGlucose Control and Vascular Complications in Veterans with Type 2 Diabetes
Duckworth, W., Abraira, C., & Möritz, T. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.02.026 · Cited by 103 · see citing works
Sundquist, K., Eriksson, U., Mezuk, B., & Ohlsson, H. (2015) · Health & Place · doi:10.1016/j.healthplace.2014.10.011 · Cited by 98 · cited 1× · see citing works
“For instance, communities with poor housing, transportation, poverty, and education have higher rates of diabetes [23-25].”
BackgroundLuo, G. (2016) · Health Information Science and Systems · doi:10.1186/s13755-016-0015-4 · Cited by 85 · cited 1× · see citing works
“To meet these goals, researchers and clinicians are using artificial intelligence (AI) to integrate electronic health records (EHRs) and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control [17-22].”
BackgroundCrowley, M. J., Holleman, R., Klamerus, M. L., Bosworth, H. B., Edelman, D., & Heisler, M. (2014) · Chronic Illness · doi:10.1177/1742395314523653 · Cited by 68 · cited 1× · see citing works
“The number of Americans with poorly controlled diabetes has been increasing, contributing to preventable morbidity and mortality [10-12].”
BackgroundClinical Quality Performance in U.S. Health Centers
Shi, L., Lebrun, L. A., Zhu, J., Hayashi, A. S., Sharma, R., Daly, C. A., Sripipatana, A., & Ngo‐Metzger, Q. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2012.01418.x · Cited by 47 · cited 1× · see citing works
“In federally qualified health centers (FQHCs), the percentage with poor control was 32% in 2016 (up from 29% in 2009), suggesting that a new approach to diabetes management is needed [13,14].”
BackgroundMicocci, M., Borsci, S., Thakerar, V., Walne, S., Manshadi, Y., Edridge, F., Mullarkey, D., Buckle, P., & Hanna, G. B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143101 · Cited by 39 · cited 1× · see citing works
“Although most of these tools have targeted specialists, 1 study examined how primary care physicians use an AI tool to diagnose skin lesions [38].”
BackgroundHarmon, D. M., Carter, R. E., Cohen-Shelly, M., Svatikova, A., Adedinsewo, D. A., Noseworthy, P. A., Kapa, S., Lopez-Jimenez, F., Friedman, P. A., & Attia, Z. I. (2022) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztac028 · Cited by 35 · cited 1× · see citing works
“For example, to address these concerns, researchers must engage communities and end users early in the development process to identify and mitigate sources of bias and iteratively test and refine the tool’s impact [45].”
BackgroundBasu, S., & Narayanaswamy, R. (2019) · Medical Care · doi:10.1097/mlr.0000000000001147 · Cited by 33 · cited 1× · see citing works
“To meet these goals, researchers and clinicians are using artificial intelligence (AI) to integrate electronic health records (EHRs) and social risk factors, such as neighborhood characteristics, to predict outcomes important to individuals with diabetes, including poor control [17-22].”
BackgroundAbdulaal, A., Patel, A., Al-Hindawi, A., Charani, E., Alqahtani, S. A., Davies, G. W., Mughal, N., & Moore, L. S. P. (2021) · JMIR Formative Research · doi:10.2196/27992 · Cited by 13 · cited 2× · see citing works
“For example, similar to our results, other clinicians have responded favorably to the usability of tools that use AI [36,37].”
BackgroundResultNational Committee on Quality Assurance (NCQA)
Stahl, M. J. (2004) · Encyclopedia of Health Care Management · doi:10.4135/9781412950602.n521 · Cited by 8 · see citing works
Semi-Structured Interview Questions
Dean, L. (2020) · doi:10.46692/9781447353270.013 · Cited by 3 · see citing works
Cutting, J. (2005) · Routledge eBooks · doi:10.4324/9780203994597-11 · Cited by 2 · see citing works
Coca, S. G., Ismail-Beigi, F., Haq, N., Krumholz, H. M., & Parikh, C. R. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2230 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Berkman, LF, 2014, Social Epidemiology (2 edition)
Cited by
Sorted by citations
Tun, H. M., Rahman, H. A., Naing, L., & Malik, O. A. (2025) · Journal of Medical Internet Research · doi:10.2196/69678 · Cited by 210 · see citing works
Rony, M. K. K., Numan, S. M., Johra, F. T., Akter, K., Akter, F., Debnath, M., Mondal, S., Wahiduzzaman, M., Das, M., Ullah, M., et al. (2024) · Health Science Reports · doi:10.1002/hsr2.70006 · Cited by 64 · see citing works
“This acceptance is supported by other studies demonstrating AI's ability to improve treatment quality through evidence ‐ based guidance 68,69 and its integration into clinical decision support systems.”
ResultLiu, Y., Liu, C., Zheng, J., Xu, C., & Wang, D. (2025) · Journal of Medical Internet Research · doi:10.2196/73374 · Cited by 63 · see citing works
“AI models based on algorithms, such as decision trees or logistic regression, can clearly demonstrate how input features influence the final output, helping clinicians understand the model’s parameters and reasoning mechanisms [46].”
InfluentialArtificial Intelligence Enabled Lifestyle Medicine in Diabetes Care: A Narrative Review
Gonzalez-Rivas, J. P., Seyedi, S. A., & Mechanick, J. I. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251359185 · Cited by 8 · see citing works
Federated multimodal AI for precision-equitable diabetes care
Bai, B., Liu, X., & Li, H. Q. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1678047 · Cited by 10 · see citing works
Chen, H., Alfred, M. C., Brown, A. D., Atinga, A., & Cohen, E. (2024) · JMIR Formative Research · doi:10.2196/59045 · Cited by 6 · see citing works
“However, a predominant challenge with most deep learning classifiers is their nontransparent nature, which can obscure the rationale behind their decision-making processes [17,18].”
Ewals, L. J. S., Heesterbeek, L. J. J., Yu, B., van der Wulp, K., Mavroeidis, D., Funk, M., Snijders, C. C. P., Jacobs, I., Nederend, J., Pluyter, J. R., et al. (2024) · JMIR AI · doi:10.2196/52211 · Cited by 7 · see citing works
Adams, A. S., Lee, C., Escobar, G. J., Bayliss, E. A., Callaghan, B. C., Horberg, M. A., Schmittdiel, J. A., Trinacty, C. M., Gilliam, L. K., Kim, E., et al. (2025) · JMIR Diabetes · doi:10.2196/60141 · Cited by 2 · see citing works
“Consistent, strong evidence from diverse datasets and health care systems will be needed to determine the use of these and other strategies for patients, providers, and health systems in the context of real-world clinical practice [46].”
Hummel, L., Lorenz-Artz, K. C. A. G., Bierbooms, J. J. P. A., & Bongers, I. M. B. (2025) · JMIR Medical Informatics · doi:10.2196/74240 · Cited by 3 · see citing works
Tun, H. M., Rahman, H. A., Naing, L., & Malik, O. A. (2024) · doi:10.2196/preprints.69678 · Cited by 1 · see citing works
Hummel, L. M., Lorenz-Artz, K., Bierbooms, J. J. P. A., & Bongers, I. M. B. (2025) · doi:10.2196/preprints.74240
Evaluating Human factors Design in Clinician-Facing AI Applications: A Scoping Review (Preprint)Preprint
Frank, C. A., Stevens, A., & Engineer, L. D. (2026) · doi:10.2196/preprints.107400
Martínez-Martínez, H., Alfonso, J. M., Sánchez-Rojo-Huertas, B., Visier‐Alfonso, M. E., Sebastián‐Valles, F., Díez‐Fernández, A., Perez-Moreno, A., & Martínez‐Vizcaíno, V. (2026) · Journal of Medical Internet Research · doi:10.2196/105329
“[27,28,31-33] a GRADE-CERQual: Grading of Recommendations Assessment, Development, and Evaluation–Confidence in the Evidence From Reviews of Qualitative Research.”
Influential
- Authors
- Liaw, W. R., Ramos Silva, Y., Soltero, E. G., Krist, A., & Stotts, A. L.
- Affiliations
- University of Houston (US)
- Baylor College of Medicine (US)
- Virginia Commonwealth University (US)
- The University of Texas Health Science Center at Houston (US)
- Venue
- JMIR AI
- Publisher
- JMIR Publications Inc.
- Published
- 2023-05-29
- Volume
- 2
- Pages
- e45032
- ISSN
- 2817-1705 (ISSN-L)
- PMC
- PMC11041401
- OpenAlex
- W4366761100
- Semantic Scholar
- dfac31a2aced37e4fe304465d7645dff5ba6e8fd
- Cited by
- 14
- References
- 43
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- JMIR AI (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Board of Family Medicine Foundation
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- diabetes mellitus, artificial intelligence, clinical decision support, HbA1c prediction, poor glycemic control, technology adoption, perceived usefulness, perceived ease of use, intention to use, electronic health record alerts, clinician perceptions, implementation barriers, tool validation, organizational support, diabetes management, health equity, federally qualified health centers, academic medical centers, clinical workflow, usability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-13.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-13.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review